The effects of etidronate on brain calcifications in Fahr ’s disease or syndrome: rationale and design of the randomised, placebo-controlled, double-blind CALCIFADE trial

Fahr ’s disease and syndrome are rare disorders leading to calcification of the small arteries in the basal ganglia of the brain, resulting in a wide range of symptoms comprising cognitive decline, movement dis...

Source: Orphanet Journal of Rare Diseases - February 7, 2024 Category: Internal Medicine Authors: Birgitta MG Snijders, Gini Mathijssen, Mike JL Peters, Marielle H Emmelot-Vonk, Pim A de Jong, Susan Bakker, Heleen A Crommelin, Ynte M Ruigrok, Eva H Brilstra, Vera PM Schepers, Wilko Spiering, Evelien van Valen and Huiberdina L Koek Tags: Research Source Type: research